Metformin Isn't What They Told You (MOTS-C Is The Real Deal) - Dr Trevor Bachmeyer

In this enlightening discussion, Dr. Trevor Bachmeyer dives into the significant differences between Metformin and a lesser-known compound, MOTS-C. He argues that while Metformin has been widely prescribed for managing diabetes and metabolic disorders, it may not be the panacea it’s often touted to be. Instead, he emphasizes that MOTS-C holds promising potential for enhancing cellular metabolism and promoting longevity beyond what traditional treatments offer.

​

Dr. Bachmeyer further explains how MOTS-C, a mitochondrial-derived peptide, works at a cellular level to improve energy utilization and reduce metabolic dysfunction. He provides insights into ongoing research and the implications this has for individuals struggling with weight management and metabolic health. As he wraps up, he encourages listeners to stay informed about emerging treatments like MOTS-C that could revolutionize our understanding of metabolic health and disease prevention.1. Metformin is not the only solution for metabolic health.

1. MOTS-C may offer superior benefits for energy metabolism.
2. MOTS-C is a mitochondrial-derived peptide with promising research.
3. Understanding new treatments can change standard approaches to health.
4. Ongoing research is crucial for discovering effective therapies.